Technique permettant d’établir un modèle d’infection bactérienne dans une culture d’organe ex vivo

Executive Industry Relevance

This ex vivo placental organ culture model enables mechanistic study of intracellular pathogen invasion at the maternal-fetal interface, supporting target validation for antimicrobial strategies. By recapitulating human trophoblast biology and Listeria monocytogenes cell-to-cell spread, the model provides predictive confidence in de-risking anti-infective candidates early in discovery. It bridges basic infection mechanisms with translational relevance for gestational infection prevention.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Interrogates therapeutic hypotheses regarding bacterial internalization via EVT receptor engagement.
• Scientific Value: Clarifies intracellular trafficking pathways involving vacuolar rupture and actin-based motility.
• Scientific Value: Supports functional validation of virulence factors as targets for mechanistic de-risking.

Screening & Assay Development

• Operational Value: Prepares standardized, infection-ready placental tissues for compound screening against intracellular pathogens.
• Operational Value: Enables quantitative readouts of bacterial spread via cell-to-cell transmission metrics.
• Operational Value: Facilitates assay reproducibility through controlled ECM-anchored organ culture preparation.

Translational & Preclinical Research

• Translational Value: Models human placental infection dynamics relevant to vertical transmission risk assessment.
• Translational Value: Aligns with biomarker discovery efforts tracking EVT-mediated pathogen dissemination.
• Translational Value: Informs preclinical go/no-go decisions by predicting tissue-level infection containment efficacy.

Pipeline & Workflow Integration

The model fits within early discovery to preclinical workflows, enabling hypothesis-driven evaluation of anti-infective mechanisms before lead optimization.

• Discovery Biology: Tests invasion inhibitors targeting internalin-EVT receptor interactions.
• Screening: Measures reduction in bacterial spread to cytotrophoblasts as a functional assay output.
• Analytics: Quantifies intracellular bacterial load and protrusion formation as mechanistic biomarkers.
• Translational Research: Connects cellular infection dynamics to tissue-level pathogenesis in gestational models.
• Enterprise Reuse: Establishes a reusable platform for screening diverse intracellular pathogens in primary human tissues.

Operational & Enterprise Impact

• Scientific Value: Reduces mechanistic ambiguity in intracellular pathogen lifecycle stages.
• Operational Value: Standardizes infection initiation and extracellular antibiotic clearance steps.
• Strategic Value: Improves target confidence by validating tissue-relevant infection models.
• Portfolio Impact: Supports risk-adjusted prioritization of anti-infectives with placental penetration potential.

Implementation Considerations

• Expertise in primary human tissue culture and extracellular matrix preparation.
• Biosafety Level 2 facilities for handling Listeria monocytogenes.
• Standardized washing and incubation protocols to ensure ECM invasion consistency.
• Adaptation considerations for other placental cell types or pathogen strains.
• Limitations include donor variability and finite tissue viability ex vivo.

Biopharma FAQs